# FDA recall Z-0746-2025

> **Becton, Dickinson and Company, BD Bio Sciences** · Class II · device recall initiated 2024-11-01.

## Product

Device Description:    FACSLyric 2L6C Instrument US, Catalog Number 662876, UDI 00382906628763    The K170974 clearance document describes the device as follows:    The BD FACSLyric" flow cytometer (3-1, 4-2, 4-2-2, and 4-3-3 optical   configurations) systems consist of a flow cytometer, sheath tank, waste tank, and a   computer workstation. System options include an automated FACS Universal Loader and   a barcode reader.  The BD FACSLyric Flow Cytometer includes the 488 nm laser and 640 nm laser as part   of four available manufactured instrument configurations.  BD FACSLyric Flow Cytometer, 3-1 configuration, 4-color/2-laser  BD FACSLyric Flow Cytometer, 4-2 configuration, 6-color/2-laser  BD FACSLyric Flow Cytometer, 4-2-2 configuration, 8-color/3-laser  BD FACSLyric Flow Cytometer, 4-3-3 configuration, 10-color/3-laser  The lower level configurations are upgradeable to higher level configurations by adding   filters, photomultiplier tubes (PMTs), and a laser. Only the 488 nm laser 

## Reason for recall

On October 18, 2024, BD has identified through customer complaints and an increase in field failures / replacements of the power supply module (part number 650781, Power Module AC-DC 250W 12/24V M3S4S6) on BD FACSLyric flow cytometers, which has the potential for the instruments to fail to power on and/or stay on. The potential power supply failure   on BD FACSLyric Flow Cytometer may lead to risks to the laboratory staff including inhalation of fumes followed by shortness of breath or coughing if failure occurs during laboratory working hours. The patient may be asked to return for additional biospecimen collection procedure and risks associated with the procedure (bruising, pain, bleeding, etc.). In addition, patient specimen loss and/ or delay providing results of testing results. There may be additional risks to the laboratory staff including inhalation of fumes followed by shortness of breath or coughing if failure occurs during laboratory working hours. In addition, the patient m

## Distribution

Worldwide - US Nationwide distribution including in the states of Alabama, Arizona, Arkansas, California, Florida, Georgia, Illinois, Indiana, Iowa, Kentucky, Maryland, Massachusetts, Michigan, Minnesota, Nebraska, New Jersey, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, Puerto Rico, Tennessee, Texas, Virginia & Wisconsin. The countries of China, Costa Rica, Singapore, Thailand.

## Key facts

- **Recall number:** Z-0746-2025
- **Recalling firm:** Becton, Dickinson and Company, BD Bio Sciences
- **Classification:** Class II
- **Product type:** device
- **Status:** Ongoing
- **Initiation date:** 2024-11-01
- **Report date:** 2025-01-01

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Milpitas, CA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-0746-2025

## Citation

> AI Analytics. FDA recall Z-0746-2025. Retrieved 2026-06-25 from https://api.ai-analytics.org/recall/Z-0746-2025. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*